Current Report Filing (8-k)
2018年10月18日 - 8:19PM
Edgar (US Regulatory)
UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
Washington,
D.C. 20549
FORM
8-K
CURRENT
REPORT
Pursuant
to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date
of report (date of earliest event reported): October 18, 2018
E-QURE
CORP.
(Exact Name of Registrant as Specified
in its Charter)
Commission
File No.: 000-54862
Delaware
|
|
47-1691054
|
(State
of Incorporation)
|
|
(I.R.S.
Employer Identification No.)
|
20
West 64th Street, Suite 39G, New York, NY
|
|
10023
|
(Address
of Principal Executive Offices)
|
|
(ZIP
Code)
|
Registrant's
Telephone Number, including area code: (972) 8-916-7333
Check
the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant
under any of the following provisions (see General Instruction A.2. below):
[ ]
|
Written
communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
|
|
|
[ ]
|
Soliciting
material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
|
|
|
[ ]
|
Pre-commencement
communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
|
|
|
[ ]
|
Pre-commencement
communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
|
Item
8.01 Other Events.
E-Qure
Corp., a Delaware corporation (the “Company”), reported today that it has successfully completed its 2018 funding
program in the total amount of $1.231 Million (the “2018 Funding Program”). The 2018 Funding Program included three
stages, which included: (1) the successfully closing of its Subscription Rights Offering pursuant to a registration statement
on Form S-1 (the “Registration Statement”); (2) the completion of the Company’s private Unit Offering pursuant
to Regulation S (the “Reg S Unit Offering”; and (3) the conversion of debt to equity by its management team, all as
discussed more fully below.
In
June 2018, the Company received net proceeds of $532,147 from the Subscription Rights Offering pursuant to the Registration Statement
that was declared effective under the Securities Act of 1933, as amended (the “Act”) by the SEC on May 10, 2018.
Following
the second quarter ended June 30, 2018, the Company, pursuant to its Reg S Unit Offering, raised an additional $423,400 from the
private sale of a total of 4,234,000 Units at $0.10 per Unit, each consisting of: (i) one share of Common Stock; (ii) one Class
A Warrant exercisable for a period of 24 months to purchase ½ share of Common Stock at the equivalent of $0.50 per share;
and (iii) one Callable Class B Warrant exercisable for a period of 36 months to purchase ½ share of Common Stock at the
equivalent of $1.25 per share. The Reg S Unit Offering was made in an “offshore transaction” to 18 accredited, all
of whom were non “U.S. Persons” as defined in Rule 902(h) promulgated by the SEC under the Act.
In
addition, after the quarter ended June 30, 2018, the Company’s executive officers and chairman converted debt in the aggregate
amount of $275,303 into units consisting of a total of: (i) 2,753,030 restricted shares, 1,376,515 Class A Warrants and Class
B Warrants, having the same terms as the Class A and Class B Warrants set forth in the Reg S Unit Offering, and 2,750,000 Class
C Warrants exercisable to purchase one share of Common Stock at a price of $1.00 per Share.
The
Company intends to use the total equity capital raised under its Registration Statement and Reg S Unit Offering for general corporate
purposes, including working capital and capital expenditures in furtherance of development and commercialization of its BST Device,
a new and novel electrotherapy for the non-invasive treatment of hard-to-heal chronic wounds. The BST Device has received
the Conformité Européenne (European Conformity -“CE”) mark and was approved to be sold in the
EU market.
SIGNATURES
Pursuant
to the requirements of the Securities Exchange Act of 1934, the Company has duly caused this report to be signed on its behalf
by the undersigned hereunto duly authorized.
|
E-QURE
CORP.
|
|
|
|
|
By:
|
/s/:
Ron Weissberg
|
|
Name:
|
Ron
Weissberg
|
|
Title:
|
Chairman
|
Date:
October 18, 2018
E Qure (CE) (USOTC:EQUR)
過去 株価チャート
から 6 2024 まで 7 2024
E Qure (CE) (USOTC:EQUR)
過去 株価チャート
から 7 2023 まで 7 2024
Real-Time news about E Qure Corporation (CE) (その他OTC): 0 recent articles
その他のE-qure Corp.ニュース記事